Latest Proof Snapshot
First-quarter 2026 sales were essentially flat at $18.0 bn, but reported operating profit fell 13% to $2.1 bn and business-segment operating margin compressed to 10.1% from 11.6%. The demand base remains substantial, with backlog of $186.4 bn at 29 March 2026, but backlog also fell from $193.6 bn at year-end 2025, so book-to-bill replenishment matters. Cash was the weak single-quarter signal: reported operating cash flow was $220 m, capex was $511 m, company-defined FCF was negative $291 m, and dividends of $816 m exceeded post-capex cash by about $1.1 bn before the scheduled $1.0 bn debt repayment. Management still reaffirmed 2026 outlook for $77.5-$80.0 bn of sales, $8.425-$8.675 bn of business-segment operating profit, and $6.5-$6.8 bn of company-defined FCF, which is why the valuation test is not demand alone but whether program margins convert backlog into cash.